Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m ...

As of the quarter ended March 31, 2026, Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) represents 14.40% of ...

Find insight on Eli Lilly, ResMed, Vertex Pharmaceuticalsand more in the latest Market Talks covering health care.

ResMed is selling its MatrixCare home-health software unit to Frazier Healthcare Partners for $490m in cash to focus on sleep and breathing care.

ResMed has agreed to sell its MatrixCare aged-care software business to private equity firm Frazier Healthcare Partners for US$490 million in cash, sharpening its strategic focus on high-growth sleep ...

Australian shares declined on Wednesday as investors reacted to a surge in oil prices on the back of renewed hostilities ...

The medical device maker has sold the MatrixCare business for less than it bought it eight years ago, with analysts pointing ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

ResMed Inc. (ASX:RMD) has moved to simplify its business and sharpen its focus on sleep, breathing and connected home ...

Citi analyst Laura Sutcliffe maintained a Hold rating on Ansell today and set a price target of A$33.50. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more ...

Resmed has agreed to sell its MatrixCare business to Seattle-based private equity firm Frazier Healthcare Partners for USD490 ...

The sleep health device manufacturer is selling its MatrixCare business to a US-based private equity firm for $707 million - ...